MADISON, WI — 18 October 2004 — NimbleGen® Systems Inc. is proud to announce the Australian Genome Research Facility (AGRF) as the newest addition to its "Custom Microarray Core Facility" program.

As a Genomics Service Provider, AGRF’s new NimbleGen Core Facility status is envisaged to "dramatically increase the breadth and scope of Australasian researchers in functional genomics through improved access to the latest in custom microarray technology," according to AGRF CEO Dr. Susan Forrest.

Using NimbleGen’s patented "Maskless Array Synthesizer" technology will enable AGRF to offer researchers ready access to highly customised high-throughput arrays of high quality at a low cost, complementing existing Affymetrix, Sequenom, and Applied Biosystems platforms. NimbleGen offers applications to advance biological research such as, ChIP arrays, microbial mutation mapping/resequencing and eukaryote copy number determination. The AGRF and NimbleGen can be contacted through www.agrf.org.au and www.nimblegen.com respectively.

Dr. Stan Rose, CEO and President of NimbleGen, commented, “We're delighted to enter into this relationship with AGRF. This will allow Australasian researchers access to many novel applications using NimbleGen's technology that go well beyond gene expression.”

About NimbleGen Systems Inc. NimbleGen Systems (http://www.nimblegen.com/) is the leading supplier of custom-designed high-density microarray products and services, offering unprecedented flexibility for genomics research. NimbleGen's Maskless Array Synthesis (MAS) technology combines photo-deposition chemistry with digital light projection to shorten array fabrication from months to hours. Customers benefit from extreme flexibility, optimized array design, highly reproducible array fabrication and statistically robust results-all with low cost and quick turnaround. NimbleGen is working with scientists around the world to develop and deploy a wide range of new microarray applications.